INNO-206
|
|
|
- CAS号:
- 151038-96-9
- 英文名:
- doxorubicin(6-maleimidocaproyl)hydrazone
- 英文别名:
- DOXO-EMCH;INNO-206;MC-DOXHZN;Aldoxorubici;Doxorubicin-EMCH;MC DOXHZN,MCDOXHZN;INNO-206 (Aldoxorubicin);Doxorubicin-hydrazone-caproyl-maleimide;doxorubicin(6-maleimidocaproyl)hydrazone;DOXO-EMCH; DOXORUBICIN-EMCH; INNO206;INNO 206;ALDOXORUBICIN
- 中文名:
- INNO-206
- 中文别名:
- 化合物 T11090
- CBNumber:
- CB51374839
- 分子式:
- C37H42N4O13
- 分子量:
- 750.74838
- MOL File:
- 151038-96-9.mol
|
|
|
INNO-206化学性质
-
密度:
-
1.60
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
酸度系数(pKa):
-
7.38±0.60(Predicted)
-
|
INNO-206性质、用途与生产工艺
MC-DOXHZN 是 Doxorubicin (DNA 拓扑异构酶 II 抑制剂) 的白蛋白结合前药，具有酸敏感性。
|
Topoisomerase II
|
Daunorubicins/Doxorubicins
|
INNO-206
上下游产品信息
上游原料
下游产品
151038-96-9, INNO-206 相关搜索:
- 原料药
- 细胞周期
- C37H42N4O13
- 化合物 T11090
- 151038-96-9
- MC DOXHZN,MCDOXHZN
- DOXO-EMCH
- MC-DOXHZN
- DOXO-EMCH; DOXORUBICIN-EMCH; INNO206;INNO 206;ALDOXORUBICIN
- 1H-Pyrrole-1-hexanoic acid, 2,5-dihydro-2,5-dioxo-, 2-[1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide
- Doxorubicin-hydrazone-caproyl-maleimide
- 1H-Pyrrole-1-hexanoicacid, 2,5-dihydro-2,5-dioxo-, [1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide
- Aldoxorubici
- N'-[(1E)-1-{4-[(3-Amino-2,3,6-trideoxyhexopyranosyl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-2-tetracenyl}-2-hydroxyethylidene]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexane hydrazide
- Doxorubicin-EMCH
- INNO-206 (Aldoxorubicin)
- INNO-206
- (E)-N'-(1-((2R,4R)-4-((2S,4R,5R,6R)-4-aMino-5-hydroxy-6-Methyltetrahydro-2H-pyran-2-yloxy)-2,5,12-trihydroxy-7-Methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-2-hydroxyethylidene)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide
- doxorubicin(6-maleimidocaproyl)hydrazone